ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 143 filers reported holding ANIKA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $668,000 | +11.9% | 12,400 | +20.4% | 0.19% | +708.7% |
| Q3 2017 | $597,000 | -44.5% | 10,300 | -52.8% | 0.02% | -36.1% |
| Q2 2017 | $1,076,000 | +11.6% | 21,800 | -28.1% | 0.04% | -2.7% |
| Q3 2015 | $964,000 | -32.9% | 30,300 | -13.2% | 0.04% | -7.5% |
| Q1 2015 | $1,437,000 | -15.5% | 34,900 | -24.8% | 0.04% | -37.5% |
| Q3 2014 | $1,701,000 | +16.2% | 46,400 | +46.8% | 0.06% | -4.5% |
| Q2 2014 | $1,464,000 | -12.3% | 31,600 | -22.2% | 0.07% | -23.0% |
| Q1 2014 | $1,669,000 | +3.4% | 40,600 | -4.0% | 0.09% | -20.9% |
| Q4 2013 | $1,614,000 | +664.9% | 42,300 | +241.1% | 0.11% | +400.0% |
| Q2 2013 | $211,000 | – | 12,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |